“
We’re finally at a point
where we will see
cancer vaccines
approved for clinical use in the near future
- Dr. Nora Disis, UW Medicine Cancer Vaccine Institute
A BOLD
COLLABORATION
TO ERASE BREAST CANCER, FASTER.
WE ARE bringing together the greatest minds in research to accelerate breast cancer vaccines.
WE ARE breast cancer survivors, leading a movement to create less damaging, more effective treatment options for everyone.
WE ARE NOT going to stop until no one else has to go through what we have.
OUR
FOUNDING STORY
Kristen and Michele, both breast cancer survivors, met when Kristen interviewed Michele for the NBC’s Today Show about Michele’s journey to survive stage 4 breast cancer and her quest to save other women from the devastating effects of the disease.
Together, they are leading this historic effort to
end breast cancer as we know it.
“
No one should have to go through painful cancer treatments, or die, when we have the science to train our own immune systems to effectively fight off cancer.
-co-founder, Kristen Dahlgren
TOGETHER WE CAN ERASE BREAST CANCER
TOGETHER WE CAN ERASE BREAST CANCER
2 minutes
how often someone in the US is diagnosed with Breast Cancer
1 in 40
how great a woman's chance is of dying from breast cancer, in the US
1 in 8
how many women in the US have a chance of developing breast cancer
in her lifetime
1 in 3
how many new female cancers in the US will be from breast cancer, each year
THE SCIENTISTS
We have assembled the top breast cancer doctors and vaccine researchers in the world for an unprecedented collaboration at a tipping point in vaccine research.
Dr. Nora Disis
UW/CVI
Dr. Larry Norton
Memorial Sloan Kettering
Dr. Powel Brown
MD Anderson Cancer Center
Dr. G. Thomas Budd
Cleveland Clinic
Dr. Beth Mittendorf
Dana-Farber/Harvard Cancer Center
Dr. Shipra Gandhi
Roswell Park Comprehensive Cancer Center
THE TIME IS NOW.
Scientists are on the cusp of
therapeutic breast cancer vaccines.
In early stage trials, vaccines have stopped
progression and prevented recurrence
in patients.
By collaborating efficiently and with Pink Eraser Project's laser focus on accelerating vaccines, scientists believe they can shave
years off of the process, bringing breast cancer vaccines to market within 5-10 years or less, saving hundreds of
thousands of lives.
